chr3-39114630-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001366900.1(TTC21A):c.604G>A(p.Val202Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000595 in 1,614,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001366900.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTC21A | NM_001366900.1 | c.604G>A | p.Val202Met | missense_variant | 6/29 | ENST00000683103.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTC21A | ENST00000683103.1 | c.604G>A | p.Val202Met | missense_variant | 6/29 | NM_001366900.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000962 AC: 24AN: 249460Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135326
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461874Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727238
GnomAD4 genome AF: 0.000315 AC: 48AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2022 | The c.604G>A (p.V202M) alteration is located in exon 6 (coding exon 6) of the TTC21A gene. This alteration results from a G to A substitution at nucleotide position 604, causing the valine (V) at amino acid position 202 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at